-
1 Comment
Welby Inc is currently in a long term downtrend where the price is trading 14.6% below its 200 day moving average.
From a valuation standpoint, the stock is 79.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 14.6.
Welby Inc's total revenue sank by 8.0% to $414M since the same quarter in the previous year.
Its net income has dropped by 198.2% to $-127M since the same quarter in the previous year.
Based on the above factors, Welby Inc gets an overall score of 1/5.
ISIN | JP3155410008 |
---|---|
Exchange | TSE |
CurrencyCode | JPY |
Sector | Healthcare |
Industry | Health Information Services |
Beta | 0.98 |
---|---|
Market Cap | 3B |
PE Ratio | None |
Target Price | None |
Dividend Yield | None |
Welby Inc. provides digital health solutions that help patients to get medical care services. The company offers services in the areas of diabetes mellitus, lifestyle related disease, mental illness, autoimmune disease, neurological disease, rare disease, oncology, and pain. It also engages in the medical data survey business; and operates apps, web services, and data management. The company was incorporated in 2011 and is based in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4438.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025